Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
opioid use disorder
overdose
take-home naloxone
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
06
07
2019
revised:
28
10
2019
accepted:
30
10
2019
pubmed:
28
11
2019
medline:
1
12
2020
entrez:
28
11
2019
Statut:
ppublish
Résumé
Take-home naloxone (THN) interventions are an effective response to preventing overdose deaths, however uptake across Australia remains limited. This project designed, implemented and evaluated a model of care targeting opioid users attending alcohol and other drug (AOD) treatment, needle and syringe programs (NSP) and related health services targeting people who inject drugs. Service providers, consumers and regulators collaboratively designed a THN brief intervention (ORTHN, Overdose Response with Take-Home Naloxone) involving client education and supply of naloxone in pre-filled syringes, delivered by nursing, allied health and NSP workers. ORTHN interventions were implemented in over 15 services across New South Wales, Australia. The evaluation included client knowledge, attitudes, substance use and overdose experiences immediately before and 3 months after ORTHN intervention in a subsample of participants. Six hundred and sixteen interventions were delivered, with 145 participants recruited to the research subsample, of whom 95 completed the three-month follow up. Overdose-related attitudes amongst participants improved following ORTHN, with no evidence of increased substance use or failure to implement other 'first responses' (e.g. calling an ambulance). Nine participants (10%) reversed an overdose using THN in the follow-up period. Participants identified a willingness to access THN from a range of services. While a minority (16%) indicated they were unwilling to pay for THN, the median price that participants were willing to pay was $AUD20 (IQR $10.40). The ORTHN model of care for THN appears an effective way to disseminate THN to people who use opioids attending AOD, NSP and related health-care settings.
Substances chimiques
Analgesics, Opioid
0
Narcotic Antagonists
0
Naloxone
36B82AMQ7N
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-65Informations de copyright
© 2019 Australasian Professional Society on Alcohol and other Drugs.
Références
Australian Bureau of Statistics. Drug Induced Deaths in Australia: A Changing Story. 2017. Available at: https://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/3303.0Main+Features62016?OpenDocument (accessed 20 May 2019).
Penington Institute. Australia's Annual Overdose Report 2018 2018. Available at: http://www.penington.org.au/australias-annual-overdose-report-2018/ (accessed 6 July 2019).
World Health Organization. Community Management of Opioid Overdose. 2014. Available at: https://apps.who.int/iris/bitstream/handle/10665/137462/9789241548816_eng.pdf (accessed 6 July 2019).
Nambiar D, Agius PA, Stoové M, Hickman M, Dietze P. Mortality in the Melbourne injecting drug user cohort study (MIX). Harm Reduct J 2015;12:55.
McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction 2016;111:1177-87.
Giglio RE, Li G, DiMaggio CJ. Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Inj Epidemiol 2015;2:10.
Dwyer R, Olsen A, Fowlie C et al. An overview of take-home naloxone programs in Australia. Drug Alcohol Rev 2018;37:440-9.
Chronister KJ, Lintzeris N, Jackson A et al. Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program. Drug Alcohol Rev 2018;37:464-71.
South Eastern Sydney Local Health District. Procedure 433. Brief Intervention for Overdose (OD) Prevention with Naloxone, 2015.
McAuley A, Aucott L, Matheson C. Exploring the life-saving potential of naloxone: a systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users. Int J Drug Policy 2015;26:1183-8.
Poisons and Therapeutic Goods Act 1966. Sect. 10 (2)(b) (2012).
Hargreaves K, Lenton S, Phillips M, Swensen G. Potential impacts on the incidence of fatal heroin-related overdose in Western Australia: a time-series analysis. Drug Alcohol Rev 2002;21:321-7.
Williams AV, Strang J, Marsden J. Development of opioid overdose knowledge (OOKS) and attitudes (OOAS) scales for take-home naloxone training evaluation. Drug Alcohol Depend 2013;132:383-6.
Ryan A, Holmes J, Hunt V et al. Validation and implementation of the Australian treatment outcomes profile in specialist drug and alcohol settings. Drug Alcohol Rev 2014;33:33-42.
Deacon RM, Mammen K, Alzaher W et al. Updating the psychometric properties of the Australian treatment outcomes profile. Drug Alcohol Rev 2017;36:28.
Smith RD. It's not just what you do, it's the way that you do it: the effect of different payment card formats and survey administration on willingness to pay for health gain. Health Econ 2006;15:281-93.
Shanahan M, Ritter A. Intangible outcomes from a policy change: using contingent valuation to quantify potential stigma from a cannabis offence. J Exp Criminol 2014;10:59-77.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. Health Informatics J 2009;42:377-81.
IBM CORP. Inventor IBM SPSS statistics for windows. Armonk: IBM CORP, 2016.
Lenton S, Dietze P, Olsen A, Wiggins N, McDonald D, Fowlie C. Working together: expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond. Drug Alcohol Rev 2015;34:404-11.
Dietze PM, Draper B, Olsen A et al. Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs. Drug Alcohol Rev 2018;37:472-9.
Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med 2013;158:1-9.
Monds L, Ridley N, Rivas C, Withall A, Draper B, Lintzeris N. Cognition and adaptive functioning in older people attending drug and alcohol services. Int Psychogeriatr 2017;29:815-23.
McAuley A, Munro A, Bird SM, Hutchinson SJ, Goldberg DJ, Taylor A. Engagement in a National Naloxone Programme among people who inject drugs. Drug Alcohol Depend 2016;162:236-40.
Madah-Amiri D, Gjersing L, Clausen T. Naloxone distribution and possession following a large-scale naloxone programme. Addiction 2019;114:92-100.
Coffin PO, Santos GM, Matheson T et al. Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: a pilot randomized controlled trial. PLoS One 2017;12:e0183354.
Goldman-Hasbun J, DeBeck K, Buxton JA, Nosova E, Wood E, Kerr T. Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study. Harm Reduct J 2017;14:79.
Damon W, Callon C, Wiebe L, Small W, Kerr T, McNeil R. Community-based participatory research in a heavily researched inner city neighbourhood: perspectives of people who use drugs on their experiences as peer researchers. Soc Sci Med 2017;176:85-92.
Greer AM, Amlani A, Pauly B, Burmeister C, Buxton JA. Participant, peer and PEEP: considerations and strategies for involving people who have used illicit substances as assistants and advisors in research. BMC Public Health 2018;18:834.
Souleymanov R, Kuzmanović D, Marshall Z et al. The ethics of community-based research with people who use drugs: results of a scoping review. BMC Med Ethics 2016;17:25.
Pitt AL, Humphreys K, Brandeau ML. Modeling health benefits and harms of public policy responses to the US opioid epidemic. Am J Public Health 2018;108:1394-400.